Online citations, reference lists, and bibliographies.
← Back to Search

A Double-blind Cross-over Trial Of A Mucin-containing Artificial Saliva

A. Duxbury, N. Thakker, D. Wastell
Published 1989 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
A double-blind, five phase, cross-over clinical trial was used to compare a mucin-based artificial saliva (Saliva Orthana) with its non-mucin base and water. Thirty patients, acting as their own controls, took part. Saliva Orthana offered significantly greater relief from xerostomia compared with its base or water, and was significantly better at relieving soreness than water. In terms of overall preference, it was ranked significantly higher than either alternative



This paper is referenced by
10.1136/EOLJNL-02-02.2
Xerostomia in terminally ill and dying patients: best practice
Lisa Sheehy (2012)
10.1177/026921639701100307
Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients
M. Sweeney (1997)
10.1111/J.1601-0825.2006.01263.X
Viscosity and wettability of animal mucin solutions and human saliva.
M. Park (2007)
10.12968/BJON.1994.3.7.332
Nurse maintenance of oral hygiene.
G. Thurgood (1994)
10.1021/bm3001292
Mucin biopolymers as broad-spectrum antiviral agents.
O. Lieleg (2012)
10.1007/s00520-010-0837-6
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact
S. Jensen (2010)
10.1016/0003-9969(90)90077-N
A new assessment in vitro of human salivary lubrication using a compliant substrate.
R. Gans (1990)
10.1016/J.ARCHORALBIO.2006.04.002
Influences of animal mucins on lysozyme activity in solution and on hydroxyapatite surfaces.
Won-Kyu Park (2006)
10.1056/NEJM199308053290603
Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
J. Johnson (1993)
Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
W. C. Ngeow (2006)
(xerostomia) in Sjögren's syndrome Treatment of oral dryness related complaints
W. V. D. Reijden (2006)
Influences of Animal Mucins on Peroxidase Activity in Solution and on the Surface of Hydroxyapatite
S. Lee (2008)
10.1007/978-88-470-2198-3_28
New Frontiers: Hyperbaric Oxygen Therapy (HBO) in Open Heart Surgery’s Complications
M. Botta (1996)
10.1016/j.archoralbio.2009.12.004
Physical and biological properties of yam as a saliva substitute.
M. Park (2010)
10.1016/j.jdent.2011.08.007
Clinical and antimicrobial evaluation of a mouthwash and toothpaste for xerostomia: a randomized, double-blind, crossover study.
M. López-Jornet (2011)
10.1111/ger.12000
Yam tuber mucilage as a candidate substance for saliva substitute: in vitro study of its viscosity and influences on lysozyme and peroxidase activities.
H. Kho (2014)
Preparation of Artificial Saliva Formulation
A. Amal (2015)
10.1002/14651858.CD008934.pub2
Interventions for the management of dry mouth: topical therapies.
S. Furness (2011)
10.1177/104990910001700212
The mouth and palliative care
M. Sweeney (2000)
10.1016/j.clindermatol.2017.06.010
Etiology, evaluation, and management of xerostomia.
J. W. Millsop (2017)
10.4103/0972-4052.43251
An in-vitro comparative study of wettability of four commercially available saliva substitutes and distilled water on heat-polymerized acrylic resin
N. Sharma (2008)
10.1016/J.IJPHARM.2004.03.022
Bioadhesive, rheological, lubricant and other aspects of an oral gel formulation intended for the treatment of xerostomia.
H. Kelly (2004)
10.1097/00002820-200108000-00001
Oral Care for Patients With Cancer: A Review of the Literature
M. Miller (2001)
10.1007/s00784-015-1488-2
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment
A. Villa (2015)
10.1016/j.ijom.2008.06.006
Effects of carboxymethylcellulose (CMC)-based artificial saliva in patients with xerostomia.
D.-J. Oh (2008)
10.1093/jncimonographs/lgz016
Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
S. B. Jensen (2019)
10.1016/j.archoralbio.2018.02.007
Effects of molecular weight of hyaluronic acid on its viscosity and enzymatic activities of lysozyme and peroxidase.
J. Kim (2018)
10.1111/J.1754-4505.1991.TB00824.X
The cause and management of burning mouth condition.
R. Basker (1991)
O EFEITO DE FRUTAS CÍTRICAS NO FLUXO SALIVAR
E. Saúde (2001)
10.1002/ART.1780390108
Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome.
W. A. van der Reijden (1996)
Influences of Saliva Substitutes on Salivary Enzymatic Activity
H. Kho (2009)
10.1039/c8bm00471d
Mucins as multifunctional building blocks of biomaterials.
Georgia Petrou (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar